WillItSurvive
Medical technology and health companies · United States

DispatchHealth

dispatchhealth.com ↗

In-home and mobile acute care service treating hospital-level cases at patients' homes.

Losing its protection
Assessed 22 July 2026 · Evidence as of 22 July 2026
The structural protection is eroding.
On the recordSince 22 July 2026 · Checkable from Q3-Q4 2026 · Every call on the record Checkpoint: First two post-waiver quarters of headcount and new health-system contract data
The call

DispatchHealth has real regulatory protection but is shrinking while the hospitals it serves learn to build the same service themselves.

DispatchHealth is a company that sends medical teams to treat patients at home instead of emergency rooms or hospitals. It is hard to copy because it has special government approval (a CMS waiver good until 2026) and partnerships with over 40 health systems, plus only about 283 hospitals nationwide are allowed to run these programs. The real problem is not a competitor copying the idea, but the hospital systems themselves deciding to run these programs on their own rather than paying DispatchHealth to do it. The company has already shrunk significantly since 2023 and left several markets, which suggests hospitals are already moving in this direction. If DispatchHealth can stop shrinking and sign new hospital partners over the next few quarters, it might survive; if hospitals keep building their own programs, DispatchHealth could become unnecessary.

Why
01
AI pressure: None apparent. AI cannot deliver bedside clinical labor; it only speeds up back-office routing and charting for DispatchHealth itself. Could AI do the core job? Unlikely.
02
Bigger players: Hospital systems building in-house hospital-at-home programs (NewYork-Presbyterian, Penn Medicine, Virtua, Kaiser). Health systems increasingly build their own at-home acute care instead of paying DispatchHealth to run it for them. Could a giant copy it? Probably.
03
What protects it. CMS hospital-at-home waiver approval and ACHC accreditation make DispatchHealth one of roughly 283 nationally approved providers, hard to replicate fast.
What would change this call
DispatchHealth headcount trend over next two quarters after May 2026 waiver extension. Growth would show stabilization; further cuts would confirm contraction.
Count of new health-system partnerships signed in 2026. 4-6+ new deals would show demand rebound; few or none would show continued retreat.
Announcements from NewYork-Presbyterian, Penn Medicine, or Virtua expanding in-house hospital-at-home programs. Would confirm hospitals are insourcing rather than buying DispatchHealth's service.
Key numbers
  • Headcount down 49.8% to ~1,003 since 2023 (Dec 2025)
  • Retreated from 10 markets through 2025 (March 2026)
  • Last disclosed valuation $1.7B (March 2021)
Named risks
  • Headcount nearly halved from ~2,000 in 2023 to ~1,003 by Dec 2025. Severity: high
  • Hospitals building in-house hospital-at-home programs rather than outsourcing to DispatchHealth. Severity: high
  • Market retreat: exited one market, scaled back in nine others during 2025. Severity: high
  • No updated post-merger valuation disclosed since March 2021 ($1.7B). Severity: medium
  • January 2026 imaging unit divestiture may signal further portfolio narrowing. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Hospital systems building in-house (NewYork-Presbyterian, Penn Medicine, Virtua)gaining onHealth systems building in-house hospital-at-home programs instead of outsourcing, flagged March 2026
Contessa HealthcontestingBenchmarked head-to-head against DispatchHealth in hospital-at-home marketplace comparisons
Inbound HealthcontestingListed alongside DispatchHealth in same Avia Health Marketplace hospital-at-home category
GetWellcontestingNamed as a peer vendor in the hospital-at-home marketplace category alongside DispatchHealth
Questions people ask
Is DispatchHealth profitable in 2026?
No public profitability figures exist. DispatchHealth is private with no disclosed financials. Its workforce fell from about 1,998 employees in 2023 to roughly 1,003 by December 2025 per Revelio Labs, a pattern more consistent with cost-cutting than confirmed profitability.
Could AI replace DispatchHealth's in-home clinicians?
No. Licensed clinicians (physicians, PAs, NPs, RNs) must physically attend patients at home, which AI cannot do. DispatchHealth's only documented AI move is a Dell AI PC rollout announced January 2026 for field staff, projecting $1.5M in savings via voice charting and transcription, not clinician replacement.
Who owns DispatchHealth?
DispatchHealth is privately held and venture-backed, with Optum Ventures (UnitedHealth Group) as a lead investor since 2020. Its last disclosed valuation was $1.7B in March 2021; no updated valuation has been made public since its May 2025 merger with Medically Home.
Who is DispatchHealth's biggest competitor?
The main pressure isn't a rival vendor but hospital systems building hospital-at-home programs in-house, including NewYork-Presbyterian, Penn Medicine, and Virtua, rather than outsourcing to DispatchHealth, according to a March 2026 industry tracker (dhinsights.org).
Has DispatchHealth had layoffs?
Workforce data from Revelio Labs shows headcount dropped to about 1,003 employees by December 2025, down 49.8% from roughly 1,998 in 2023, coinciding with the company exiting one market and scaling back in nine others during 2025.
What business did DispatchHealth sell off recently?
DispatchHealth divested its mobile imaging business unit to TridentCare, effective January 20, 2026, narrowing its service lines to core acute and hospital-at-home care following its May 2025 merger with Medically Home.
Timeline
  • 2026-05-18COO Erin Bartley elevated to President amid post-merger reorganization
  • 2026-05Congress extended CMS Acute Hospital Care at Home waiver for five years
  • 2026-02-06Launched hospital-at-home JV with Saint Francis Health System, Tulsa OK
  • 2026-01-20Divested mobile imaging business unit to TridentCare
  • 2025-06-04Medically Home merger officially closed, brand phased out
  • 2025-03-18Merger with Medically Home announced; ACHC In-Home Hospital Care accreditation achieved
  • 2022-11-23Raised $259M equity plus $75M debt, cumulative funding surpassing $400M
  • 2021-03-03Last public valuation snapshot set at $1.7B
  • 2020-06-01Closed $135.8M Series C led by Optum Ventures
  • 2013Founded in Denver, Colorado by Dr. Mark Prather and Kevin Riddleberger
Revision history
22 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
NeuralinkKingmed DiagnosticsMeinian Onehealth
More in Medical technology and health companies →
Sources